» Articles » PMID: 21139110

Integrating Tobacco Cessation into Mental Health Care for Posttraumatic Stress Disorder: a Randomized Controlled Trial

Abstract

Context: Most smokers with mental illness do not receive tobacco cessation treatment.

Objective: To determine whether integrating smoking cessation treatment into mental health care for veterans with posttraumatic stress disorder (PTSD) improves long-term smoking abstinence rates.

Design, Setting, And Patients: A randomized controlled trial of 943 smokers with military-related PTSD who were recruited from outpatient PTSD clinics at 10 Veterans Affairs medical centers and followed up for 18 to 48 months between November 2004 and July 2009.

Intervention: Smoking cessation treatment integrated within mental health care for PTSD delivered by mental health clinicians (integrated care [IC]) vs referral to Veterans Affairs smoking cessation clinics (SCC). Patients received smoking cessation treatment within 3 months of study enrollment.

Main Outcome Measures: Smoking outcomes included 12-month bioverified prolonged abstinence (primary outcome) and 7- and 30-day point prevalence abstinence assessed at 3-month intervals. Amount of smoking cessation medications and counseling sessions delivered were tested as mediators of outcome. Posttraumatic stress disorder and depression were repeatedly assessed using the PTSD Checklist and Patient Health Questionnaire 9, respectively, to determine if IC participation or quitting smoking worsened psychiatric status.

Results: Integrated care was better than SCC on prolonged abstinence (8.9% vs 4.5%; adjusted odds ratio, 2.26; 95% confidence interval [CI], 1.30-3.91; P = .004). Differences between IC vs SCC were largest at 6 months for 7-day point prevalence abstinence (78/472 [16.5%] vs 34/471 [7.2%], P < .001) and remained significant at 18 months (86/472 [18.2%] vs 51/471 [10.8%], P < .001). Number of counseling sessions received and days of cessation medication used explained 39.1% of the treatment effect. Between baseline and 18 months, psychiatric status did not differ between treatment conditions. Posttraumatic stress disorder symptoms for quitters and nonquitters improved. Nonquitters worsened slightly on the Patient Health Questionnaire 9 relative to quitters (differences ranged between 0.4 and 2.1, P = .03), whose scores did not change over time.

Conclusion: Among smokers with military-related PTSD, integrating smoking cessation treatment into mental health care compared with referral to specialized cessation treatment resulted in greater prolonged abstinence.

Trial Registration: clinicaltrials.gov Identifier: NCT00118534.

Citing Articles

Understanding HIV care providers' support for tobacco cessation among people living with HIV in Western Kenya: a formative qualitative study.

Kwena Z, Bukusi E, Ongeri L, Shade S, Vijayaraghavan M, Odhiambo F BMJ Public Health. 2025; 2(1):e000776.

PMID: 40018225 PMC: 11812872. DOI: 10.1136/bmjph-2023-000776.


Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial.

Cinciripini P, Minnix J, Kypriotakis G, Erasmus J, Beneventi D, Karam-Hage M JAMA Intern Med. 2025; 185(3):284-291.

PMID: 39804633 PMC: 11877161. DOI: 10.1001/jamainternmed.2024.7288.


Smoking as a Marker of Comorbid Vulnerability Among Persons with Probable Posttraumatic Stress Disorder Who Engage in Hazardous Drinking.

Zvolensky M, Smit T, Salwa A, Clausen B, Robison J, Raines A Subst Use Misuse. 2025; 60(5):692-703.

PMID: 39791598 PMC: 11870801. DOI: 10.1080/10826084.2024.2447418.


Multimodal smoking cessation treatment combining repetitive transcranial magnetic stimulation, cognitive behavioral therapy, and nicotine replacement in veterans with posttraumatic stress disorder: A feasibility randomized controlled trial protocol.

Young J, Polick C, Michael A, Dannhauer M, Galla J, Evans M PLoS One. 2024; 19(9):e0291562.

PMID: 39240791 PMC: 11379281. DOI: 10.1371/journal.pone.0291562.


Cessation of Smoking Trial in the Emergency Department (COSTED): a multicentre randomised controlled trial.

Pope I, Clark L, Clark A, Ward E, Belderson P, Stirling S Emerg Med J. 2024; 41(5):276-282.

PMID: 38531658 PMC: 11041600. DOI: 10.1136/emermed-2023-213824.


References
1.
Tunis S, Stryer D, Clancy C . Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003; 290(12):1624-32. DOI: 10.1001/jama.290.12.1624. View

2.
Cook J, McFall M, Calhoun P, Beckham J . Posttraumatic stress disorder and smoking relapse: A theoretical model. J Trauma Stress. 2007; 20(6):989-98. DOI: 10.1002/jts.20275. View

3.
BROWN R, Kahler C, Niaura R, Abrams D, Sales S, Ramsey S . Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001; 69(3):471-80. PMC: 1832078. DOI: 10.1037//0022-006x.69.3.471. View

4.
Hall S, Prochaska J . Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol. 2009; 5:409-31. PMC: 2718730. DOI: 10.1146/annurev.clinpsy.032408.153614. View

5.
Fu S, McFall M, Saxon A, Beckham J, Carmody T, Baker D . Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res. 2007; 9(11):1071-84. DOI: 10.1080/14622200701488418. View